Unknown OBSERVATIONAL NCT03965572

Factors and Outcomes Associated With Postpartum Cabergoline Use

Factors and Outcomes Associated With Use of Cabergoline Among Postpartum Women in Israel

Sponsor: Laniado Hospital

Conditions Cabergoline Adverse Reaction Lactation Suppressed Postpartum DVT Postpartum Depression

Updated 7 times since 2019 Last updated: Sep 27, 2021 Started: Jun 7, 2019 Primary completion: Dec 31, 2022 Completion: May 12, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Cabergoline Adverse Reaction and Lactation Suppressed, this trial is ongoing. The trial is conducted by Laniado Hospital and has accumulated 7 data snapshots since 2019. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Oct 2023 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Oct 2021 — Oct 2023 [monthly]

Recruiting
Jan 2021 — Oct 2021 [monthly]

Recruiting

▶ Show 2 earlier versions

Mar 2020 — Jan 2021 [monthly]

Recruiting
Jun 2019 — Mar 2020 [monthly]

Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Laniado Hospital

Data source: Laniado Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Netanya, Israel